PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 4, 20260 citations

Bilateral peripheral exudative hemorrhagic chorioretinopathy treated with intravitreal injections of ranibizumab.

View Full Paper
AEA B González EscobarHospital Clínico Universitario Virgen de la VictoriaIAI M Baquero ArandaHospital Clínico Universitario Virgen de la VictoriaJÁJ C Valera ÁvilaHospital Clínico Universitario Virgen de la Victoria

Key Points

  • This study aims to highlight the diagnosis and treatment of bilateral peripheral exudative hemorrhagic chorioretinopathy (PEHCR) in an elderly patient.
  • Emergency department presentation of an 89-year-old woman with visual acuity loss due to PEHCR.
  • Diagnosis established through ophthalmological examination and multimodal imaging.
  • Management involved intravitreal injections of anti-VEGF, specifically ranibizumab.
  • Visual acuity improved following treatment, though specific metrics are not provided.
  • Successful recognition and diagnosis of PEHCR facilitated timely intervention with anti-VEGF therapy.
  • Contributes to literature emphasizing the relevance of PEHCR in elderly patients with peripheral retinal lesions.

Abstract

Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is a rare entity consisting of lesions similar to those of age-related macular degeneration (AMD) and type 1 aneurysmal neovascularization (N1a), but located outside the macular region in the peripheral retina. We present the case of an 89-year-old woman who presented to the emergency department with loss of visual acuity (VA) in both eyes (OU) due to a massive macular subretinal hemorrhage in the right eye (OD) and a vitreous hemorrhage in her left eye (OS), accompanied in both eyes by peripheral hemorrhagic retinal pigment epithelium detachments (HPED). Ophthalmological examination and multimodal imaging led to the diagnosis of PEHCR. This case highlights the importance of the differential diagnosis of PEHCR from other vascular and neoplastic pathologies in order to avoid unnecessary tests and treatments. Early recognition and diagnosis are essential for establishing appropriate management, with intravitreal injections of anti-vascular endotelial groth factors (anti-VEGF) being recommended in cases with loss of VA or threat thereof. This case also contributes to the limited published literature on bilateral PEHCR, reinforcing the need to consider this pathology in elderly patients with peripheral hemorrhagic lesions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Escobar et al. (2026) studied this question.

synapsesocial.com/papers/69f837933ed186a739981bbdhttps://doi.org/10.1016/j.oftale.2026.502539
Ask AI
Helpful
Bookmark
Share
View Full Paper